Published in Food Chem Toxicol on April 01, 1998
Chicken liver ribosomes: characterization of cross-reaction and inhibition of some functions by antibodies prepared against Escherichia coli ribosomal proteins L7 and L12. J Mol Biol (1976) 12.86
Polymorphic hydroxylation of Debrisoquine in man. Lancet (1977) 9.36
Changes in physicians' attitudes toward telling the cancer patient. JAMA (1979) 7.75
A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. J Med Genet (1980) 5.68
Biliary excretion of foreign compounds. Biphenyl, stilboestrol and phenolphthalein in the rat: molecular weight, polarity and metabolism as factors in biliary excretion. Biochem J (1967) 5.33
More on SI units. N Engl J Med (1992) 4.34
Biliary excretion of foreign compounds. Benzene and its derivatives in the rat. Biochem J (1967) 3.97
Lowry determination of protein in the presence of Triton X-100. Anal Biochem (1975) 3.94
Polymorphism of carbon oxidation of drugs and clinical implications. Br Med J (1978) 3.90
Rho1p, a yeast protein at the interface between cell polarization and morphogenesis. Science (1996) 3.42
Effect of organic contamination upon microbial distributions and heterotrophic uptake in a Cape Cod, Mass., aquifer. Appl Environ Microbiol (1984) 3.06
Denitrification in san francisco bay intertidal sediments. Appl Environ Microbiol (1984) 3.03
Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J Pharmacol Exp Ther (1991) 2.96
The "cause of death" is dying. Mod Pathol (1993) 2.68
Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science (1993) 2.60
Phosphate-regulated inactivation of the kinase PHO80-PHO85 by the CDK inhibitor PHO81. Science (1994) 2.57
Biliary excretion in foreign compounds. Sulphonamide drugs in the rat. Biochem J (1967) 2.53
Biliary excretion in foreign compounds. Species difference in biliary excretion. Biochem J (1967) 2.52
International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev (1996) 2.43
Impaired oxidation of debrisoquine in patients with perhexiline neuropathy. Br Med J (Clin Res Ed) (1982) 2.39
The metabolism of [14C]-debrisoquine in man. Br J Clin Pharmacol (1979) 2.29
Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology (1995) 2.26
Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists. Life Sci (1987) 2.19
Body malodour syndromes. Lancet (1995) 2.12
The future of environmental and toxicologic pathology. Hum Pathol (1996) 2.10
Nitrogen Fixation in Grasses Inoculated with Spirillum lipoferum. Science (1976) 2.09
Interindividual and interspecies variation in the metabolism of the hallucinogen 4-methoxyamphetamine. Xenobiotica (1979) 2.07
Science, medicine, and the future: Pharmacogenetics. BMJ (2000) 2.06
Safety evaluation and risk assessment of the herbicide Roundup and its active ingredient, glyphosate, for humans. Regul Toxicol Pharmacol (2000) 1.97
Trimethylaminuria: the fish malodor syndrome. Drug Metab Dispos (2001) 1.96
The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions. J Med Genet (1983) 1.92
Reovirus infection and tissue injury in the mouse central nervous system are associated with apoptosis. J Virol (1997) 1.90
Dietary precursors of trimethylamine in man: a pilot study. Food Chem Toxicol (1999) 1.90
Quantitation of glycosaminoglycan hexosamine using 3-methyl-2-benzothiazolone hydrazone hydrochloride. Anal Biochem (1979) 1.85
Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome. Nat Genet (1997) 1.83
A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities. J Med Chem (1980) 1.80
The metabolic fate of amphetamine in man and other species. Biochem J (1970) 1.80
Maximal power across the lifespan. J Gerontol A Biol Sci Med Sci (2000) 1.78
A fibronectin receptor on Candida albicans mediates adherence of the fungus to extracellular matrix. J Infect Dis (1991) 1.78
The exogenous origin of trimethylamine in the mouse. Metabolism (1992) 1.78
The biliary excretion of tartrazine. Sex differences in the rat and species differences in the rat, guinea-pig and rabbit. J Pharm Pharmacol (1972) 1.77
Assessment of major and daily stressful events during adolescence: the Adolescent Perceived Events Scale. J Consult Clin Psychol (1987) 1.74
Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J Pharmacol Exp Ther (1988) 1.73
Polymorphisms of oxidation at carbon centers of drugs and their clinical significance. Drug Metab Rev (1979) 1.71
D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3. J Rheumatol (1984) 1.69
Nerve growth factor-dependence of herpes simplex virus latency in peripheral sympathetic and sensory neurons in vitro. J Neurosci (1990) 1.69
Comparison of low- and high-passage bovine turbinate cells for assay of bovine viral diarrhea virus. Arch Gesamte Virusforsch (1974) 1.65
Use of molecular techniques to evaluate the survival of a microorganism injected into an aquifer. Appl Environ Microbiol (1994) 1.64
Range-finding toxicity data: List VII. Am Ind Hyg Assoc J (1969) 1.63
The fate of benzoic acid in various species. Biochem J (1970) 1.62
The metabolism of thalidomide: the fate of thalidomide and some of its hydrolysis products in various species. Br J Pharmacol Chemother (1965) 1.62
Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS (1990) 1.61
Short-term adaptation in single auditory nerve fibers: some poststimulatory effects. J Neurophysiol (1977) 1.59
Painful peripheral diabetic neuropathy treated with venlafaxine HCl extended release capsules. Diabetes Care (1999) 1.58
The fish odour syndrome: biochemical, familial, and clinical aspects. BMJ (1993) 1.57
Species variations in the threshold molecular-weight factor for the biliary excretion of organic anions. Biochem J (1972) 1.57
The influence of dietary methylxanthines on the metabolism and pharmacokinetics of intravenously administered theophylline [proceedings]. Br J Clin Pharmacol (1977) 1.55
Hypotensive response to debrisoquine and hydroxylation phenotype. Life Sci (1978) 1.55
Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Crit Rev Toxicol (2007) 1.54
Effects of kappa opioids on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther (1997) 1.52
Rapid and short-term adaptation in auditory nerve responses. Hear Res (1984) 1.52
The fate of amphetamine in man and other mammals. J Pharm Pharmacol (1966) 1.51
Signaling pathways for tumor necrosis factor-alpha and interleukin-6 expression in human macrophages exposed to titanium-alloy particulate debris in vitro. J Bone Joint Surg Am (1999) 1.49
Inhibition of existing denitrification enzyme activity by chloramphenicol. Appl Environ Microbiol (1992) 1.47
Physician knowledge in the use of canister nebulizers. Chest (1983) 1.47
The metabolism of thalidomide: the spontaneous hydrolysis of thalidomide in solution. Br J Pharmacol Chemother (1965) 1.46
Alteration of the Fe protein of nitrogenase by oxygen in the cyanobacterium Anabaena sp. strain CA. J Bacteriol (1987) 1.44
The metabolism of 14C-labelled trimethylamine and its N-oxide in man. Xenobiotica (1987) 1.44
A genetic polymorphism of the N-oxidation of trimethylamine in humans. Clin Pharmacol Ther (1987) 1.44
Prediction of glycosaminoglycan content in human cartilage by age, T1ρ and T2 MRI. Osteoarthritis Cartilage (2010) 1.43
Dynamic structure of membranes by deuterium NMR. Science (1984) 1.43
Prophylactic antibiotics in clean orthopaedic surgery. J Bone Joint Surg Am (1974) 1.43
Glucosaminidase, galactosaminidase, and glucuronidase in the growth plate. J Orthop Res (1990) 1.42
An information service for practicing veterinarians. Bull Med Libr Assoc (1978) 1.42
Embryotoxic activity of some pesticides and drugs related to phthalimide. Food Cosmet Toxicol (1965) 1.40
Estimation of toxic hazard--a decision tree approach. Food Cosmet Toxicol (1978) 1.40
The self-appointed purifiers of science. Mod Pathol (1992) 1.39
Drug related vasculitis. Clinicopathologic correlations in 30 patients. Hum Pathol (1979) 1.38
VBEC: very busy endothelial cell. Mod Pathol (1994) 1.38
Bile and urine as complementary pathways for the excretion of foreign organic compounds. Xenobiotica (1976) 1.38
Adaptation, saturation, and physiological masking in single auditory-nerve fibers. J Acoust Soc Am (1979) 1.36
Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1. J Clin Invest (1993) 1.36
Bactericidal Activity of TiO2 Photocatalyst in Aqueous Media: Toward a Solar-Assisted Water Disinfection System. Environ Sci Technol (1994) 1.35
Pharmacological characterization in vivo of the novel opiate, beta-funaltrexamine. J Pharmacol Exp Ther (1982) 1.35
Encoding of amplitude modulation in the gerbil cochlear nucleus: I. A hierarchy of enhancement. Hear Res (1990) 1.35
Organization of the genes necessary for hydrogenase expression in Rhodobacter capsulatus. Sequence analysis and identification of two hyp regulatory mutants. Mol Microbiol (1993) 1.34
Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats. Atherosclerosis (2000) 1.34
Selection of the valid number of sampling units and a consideration of their combination in toxicological studies involving reproduction, teratogenesis or carcinogenesis. Food Cosmet Toxicol (1970) 1.33
Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors. J Pharmacol Exp Ther (1992) 1.32
Histoplasmosis in patients at risk for the acquired immunodeficiency syndrome in a nonendemic setting. Chest (1988) 1.32
Canine mitral complex. Ultrastructure and electromechanical properties. Circ Res (1972) 1.31
Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man. Br J Clin Pharmacol (1984) 1.29
Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists. Trends Pharmacol Sci (1989) 1.27
Isolation of Azospirullum from diverse geographic regions. Can J Microbiol (1979) 1.26
Influence of DH/DL alleles regulating debrisoquine oxidation on phenytoin hydroxylation. Clin Pharmacol Ther (1981) 1.26
Electrophysiological properties of cardiac muscle in the anterior mitral valve leaflet and the adjacent atrium in the dog. Possible implications for the genesis of atrial dysrhythmias. Circ Res (1973) 1.25
5'-Guanidinonaltrindole, a highly selective and potent kappa-opioid receptor antagonist. Eur J Pharmacol (2000) 1.23
Protecting poor metabolizers, a group at high risk of adverse drug reactions. Lancet (1983) 1.23
Cloning of the mgtE Mg2+ transporter from Providencia stuartii and the distribution of mgtE in gram-negative and gram-positive bacteria. J Bacteriol (1995) 1.22
The fibronectin adhesin of Candida albicans. Infect Immun (1994) 1.22